- Journal title changes from Korean Journal of Urology to Investigative and Clinical Urology
-
Park K
- KMID: 2363118
- Investig Clin Urol.
- 2016 Jan;57(1):1-2.
- doi: 10.4111/icu.2016.57.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of active surveillance in prostate cancer
-
Chung MS, Lee SH
- KMID: 2363120
- Investig Clin Urol.
- 2016 Jan;57(1):14-20.
- doi: 10.4111/icu.2016.57.1.14
Active surveillance (AS) is a management strategy involving close monitoring the course of disease with the expectation to intervene if the cancer progress, in a super-selected group of low-risk prostate... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean clinical practice guideline for benign prostatic hyperplasia
-
Yeo JK, Choi H, Bae JH, Kim JH, Yang SO, Oh CY, Cho YS, Kim KW, Kim HJ
- KMID: 2363122
- Investig Clin Urol.
- 2016 Jan;57(1):30-44.
- doi: 10.4111/icu.2016.57.1.30
In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the... -
- CITED
-
- Close
- SHARE
-
- Close
- The artificial urinary sphincter and male sling for postprostatectomy incontinence: Which patient should get which procedure?
-
Comiter CV, Dobberfuhl AD
- KMID: 2363119
- Investig Clin Urol.
- 2016 Jan;57(1):3-13.
- doi: 10.4111/icu.2016.57.1.3
Surgery is the most efficacious treatment for postprostatectomy incontinence. The ideal surgical approach depends on a variety of patient factors including history of prior incontinence surgery or radiation treatment, bladder... -
- CITED
-
- Close
- SHARE
-
- Close
- Chromosomal aberrations in benign prostatic hyperplasia patients
-
Altok M, Bagci O, Umul M, Gunes M, Akyuz M, Uruc F, Uz E, Soyupek S
- KMID: 2363123
- Investig Clin Urol.
- 2016 Jan;57(1):45-49.
- doi: 10.4111/icu.2016.57.1.45
PURPOSE: To investigate the chromosomal changes in patients with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: A total of 54 patients diagnosed with clinical BPH underwent transurethral prostate resection to address... -
- CITED
-
- Close
- SHARE
-
- Close
- Secondary surgery for vesicoureteral reflux after failed endoscopic injection: Comparison to primary surgery
-
Lee S, Jeong SC, Chung JM, Lee SD
- KMID: 2363125
- Investig Clin Urol.
- 2016 Jan;57(1):58-62.
- doi: 10.4111/icu.2016.57.1.58
PURPOSE: As endoscopic treatment for vesicoureteral reflux (VUR) has increased, secondary ureteral reimplantation (UR) after failure of endoscopic treatment has increased. We studied the clinical feature and efficacy of secondary... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic efficacy of nanomedicines for prostate cancer: An update
-
Lakshmanan VK
- KMID: 2363121
- Investig Clin Urol.
- 2016 Jan;57(1):21-29.
- doi: 10.4111/icu.2016.57.1.21
Recent advances in cancer nanomedicine have attracted remarkable attention in medical sectors. Pharmacologic research on nanomedicines, including targeted cancer therapy, has increased dramatically in the past 5 years. The success... -
- CITED
-
- Close
- SHARE
-
- Close
- The establishment of KORCC (KOrean Renal Cell Carcinoma) database
-
Byun SS, Hong SK, Lee S, Kook HR, Lee E, Kim HH, Kwak C, Ku JH, Jeong CW, Lee JY, Hong SH, Kim YJ, Hwang EC, Kwon TG, Kim TH, Kang SH, Kim SH, Chung J
- KMID: 2363124
- Investig Clin Urol.
- 2016 Jan;57(1):50-57.
- doi: 10.4111/icu.2016.57.1.50
PURPOSE: The purpose of this article is to report establishment of the 1st Web-based database (DB) system to collect renal cell carcinoma (RCC) data in Korea. MATERIALS AND METHODS: The new... -
- CITED
-
- Close
- SHARE
-
- Close
- Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines
-
Kim SH, Ho JN, Jin H, Lee SC, Lee SE, Hong SK, Lee JW, Lee ES, Byun SS
- KMID: 2363126
- Investig Clin Urol.
- 2016 Jan;57(1):63-72.
- doi: 10.4111/icu.2016.57.1.63
PURPOSE: The mechanism of resistance to cisplatin during treatment of bladder cancer (BC) has been a subject of intense investigation in clinical research. This study aims to identify candidate genes... -
- CITED
-
- Close
- SHARE
-
- Close
